0001562180-22-004031.txt : 20220516 0001562180-22-004031.hdr.sgml : 20220516 20220516160828 ACCESSION NUMBER: 0001562180-22-004031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220512 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burke Steven Keith CENTRAL INDEX KEY: 0001619834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 22928911 MAIL ADDRESS: STREET 1: 82 WILLIS ROAD CITY: SUDBURY STATE: MA ZIP: 01776 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-05-12 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001619834 Burke Steven Keith C/O AKEBIA THERAPEUTICS, INC 245 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, Chief Medical Officer Common Stock 2022-05-12 4 A false 200000.00 0.00 A 417663.00 D Stock Option (Right to buy) 0.41 2022-05-12 4 A false 200000.00 0.00 A 2023-05-12 2032-05-12 Common Stock 200000.00 200000.00 D The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date. The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date. /s/ Carolyn Rucci, attorney-in-fact for Steven K. Burke 2022-05-16